Form 4: FactSet Director Exercises Stock Options and Sells Shares in Pre-Planned Transactions

Sentiment:

Insider Transaction Report


FactSet Research Systems Inc. Director James J. McGonigle exercised stock options and subsequently sold an equivalent number of common shares in pre-planned transactions on July 14, 2025.

Summary

  • James J. McGonigle, a Director at FactSet Research Systems Inc. (FDS), engaged in a series of transactions on July 14, 2025, under a Rule 10b5-1(c) pre-planned trading arrangement.
  • McGonigle exercised Non-Employee Director Stock Options to acquire 2,010 shares of common stock at an exercise price of $271.51 per share. These options were granted on January 15, 2020, and vested on January 15, 2023.
  • Additionally, McGonigle exercised Non-Employee Director Stock Options to acquire 915 shares of common stock at an exercise price of $318.20 per share. These options were granted on January 15, 2021, and vested on January 15, 2024.
  • Immediately following the option exercises, McGonigle sold a total of 2,925 shares of common stock.
  • The sales included 300 shares at a weighted average price of $449.93, 1,200 shares at a weighted average price of $451.05, and 1,425 shares at a weighted average price of $451.98.
  • Following these transactions, McGonigle's direct beneficial ownership of FactSet common stock is 4,461 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a director selling shares can sometimes be viewed negatively, these are pre-planned transactions (Rule 10b5-1) involving the exercise of options and immediate sale, which is a standard practice for liquidity and tax planning, rather than an indication of a change in company outlook.

Positives

  • The exercise of stock options indicates that the options were in-the-money, allowing the director to realize value from their equity compensation.
  • The transactions were conducted under a Rule 10b5-1(c) plan, indicating they were pre-planned and not based on immediate, non-public information.

Negatives

  • The sale of 2,925 shares by a director reduces their direct ownership stake in the company, which some investors might interpret as a lack of confidence, although it is a common liquidity event.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Primarily impacts the reporting person, James J. McGonigle, by allowing him to realize value from his equity compensation.
  • Has a minor impact on the public float of FactSet Research Systems Inc. common stock due to the sale of shares.

Key Dates

DateDescription
2020-01-15Grant date for 2,010 Non-Employee Director Stock Options.
2021-01-15Grant date for 915 Non-Employee Director Stock Options.
2023-01-15Vesting date for 2,010 Non-Employee Director Stock Options.
2024-01-15Vesting date for 915 Non-Employee Director Stock Options.
2025-07-14Date of option exercises and subsequent sale of common stock.
2025-07-15Filing date of the Form 4 statement.
2027-01-15Expiration date for 2,010 Non-Employee Director Stock Options.
2028-01-15Expiration date for 915 Non-Employee Director Stock Options.

Keywords

FactSet Research Systems Inc., FDS, James J. McGonigle, Director, Insider Transaction, Form 4, Stock Options, Share Sale, Beneficial Ownership, Rule 10b5-1, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.